Karan Agri Genetics Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 20.00 Cr
- Revenue Growth 21.90%
- Profit Growth 50.29%
- Ebitda 33.03%
- Net Worth 60.38%
- Total Assets 37.63%
About Karan Agri Genetics
Karan Agri Genetics Private Limited (KAGPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 13 June 2012 and has a history of 12 years and eight months. Its registered office is in Junagadh, Gujarat, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹20.00 Cr.
Kiranbhai Kapadiya, Pravin Sojitra, Rasikbhai Shiroya, and One other member serve as directors at the Company.
Company Details
- Location
Junagadh, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U01403GJ2012PTC070712
- Company No.
070712
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jun 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Karan Agri Genetics?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kiranbhai Kapadiya  | Director | 13-Jun-2012 | Current |
| Pravin Sojitra | Director | 13-Jun-2012 | Current |
| Rasikbhai Shiroya | Director | 13-Jun-2012 | Current |
| Shobhanaben Sojitra | Director | 13-Jun-2012 | Current |
Financial Performance of Karan Agri Genetics.
Karan Agri Genetics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 21.9% increase. The company also saw a substantial improvement in profitability, with a 50.29% increase in profit. The company's net worth Soared by an impressive increase of 60.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Karan Agri Genetics?
In 2022, Karan Agri Genetics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹200.00 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 20.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Dec 2018 | Axis Bank Limited | ₹20.00 Cr | Open |
How Many Employees Work at Karan Agri Genetics?
Unlock and access historical data on people associated with Karan Agri Genetics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Karan Agri Genetics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Karan Agri Genetics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.